Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients

被引：8

作者：

Moldovan, Diana ^{[1
]}

Kacso, Ina Maria ^{[1
]}

Rusu, Crina ^{[1
]}

Potra, Alina ^{[1
]}

Bondor, Cosmina Ioana ^{[2
]}

Moldovan, Ioan ^{[3
]}

Patiu, Ioan Mihai ^{[4
]}

Vladutiu, Dan ^{[1
]}

Caprioara, Mirela Gherman ^{[1
]}

机构：

[1] Univ Med & Pharm Iuliu Hatieganu, Dept Nephrol, Cluj Napoca, Romania

[2] Univ Med & Pharm Iuliu Hatieganu, Dept Stat, Cluj Napoca, Romania

[3] Emergency Mil Hosp, Cluj Napoca, Romania

[4] Nefromed Dialysis Ctr, Cluj Napoca, Romania

来源：

BIOMARKERS | 2015年 / 20卷 / 02期

关键词：

Cardiovascular disease; immunotoxicity; renal disease; CHRONIC KIDNEY-DISEASE; INTIMA-MEDIA THICKNESS; SERUM OSTEOPROTEGERIN; CARDIOVASCULAR EVENTS; FETUIN-A; ELEVATED OSTEOPROTEGERIN; CALCIFICATION INHIBITORS; PLASMA OSTEOPROTEGERIN; HEMODIALYSIS; ARTERY;

D O I：

10.3109/1354750X.2014.1000376

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To assess the osteoprotegerin (OPG) relationship with cardiovascular complications in hemodialysis (HD) patients. Methods: The study included 87 HD patients. Clinical characteristics, ankle-arm index (AAI), OPG and mineral markers levels were recorded. Arterial intimal calcification (AIC) and arterial medial calcification (AMC) were registered. Results: OPG levels were increased in HD patients. Patients with AIC (p = 0.006)/ AMC (p = 0.01) had higher OPG levels. OPG did not have any relation with cardiovascular diseases. OPG correlated positively with age, increased HD vintage and inversely with albumin and AAI. OPG has not been a risk factor for VC or cardiovascular disease. Conclusion: OPG rising could be a reaction in defense to vascular aggression, because OPG was associated with VC, but not with vascular disease.

引用

页码：116 / 122

页数：7

共 50 条

[31] Role of turmeric in oxidative modulation in end-stage renal disease patients
Pakfetrat, Maryam
Akmali, Masoumeh
Malekmakan, Leila
Dabaghimanesh, Mojtaba
Khorsand, Marjan
HEMODIALYSIS INTERNATIONAL, 2015, 19 (01) : 124 - 131
[32] ROLE OF CLINICAL TRANSPLANTATION IN PATIENTS WITH END-STAGE RENAL-DISEASE
BELZER, FO
KOUNTZ, SL
TRANSPLANTATION PROCEEDINGS, 1973, 5 (01) : 793 - 797
[33] THE ROLE OF INTERVENTIONAL RADIOLOGY IN THE MANAGEMENT OF PATIENTS WITH END-STAGE RENAL DISEASE
Tisnado, Jaime
Tisnado, Jamie
Sydnor, Malcolm K.
Komorowski, Daniel J.
JOURNAL OF ENDOUROLOGY, 2011, 25 : A133 - A133
[34] The clinical significance of vascular calcification in young patients with end-stage renal disease
Querfeld, U
PEDIATRIC NEPHROLOGY, 2004, 19 (05) : 478 - 484
[35] Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients
Bowden, RG
Wyatt, FB
Wilson, R
Wilborn, C
Gentile, M
RENAL FAILURE, 2004, 26 (06) : 709 - 714
[36] The clinical significance of vascular calcification in young patients with end-stage renal disease
Uwe Querfeld
Pediatric Nephrology, 2004, 19 : 478 - 484
[37] STAGED VASCULAR ACCESS FOR HEMODIALYSIS IN END-STAGE RENAL-DISEASE PATIENTS
JIRASIRITHAM, S
PANICHAPAN, S
SUMETHKUL, V
JIRASIRITHAM, S
TRANSPLANTATION PROCEEDINGS, 1992, 24 (04) : 1461 - 1461
[38] Recent Advances in the Management of Vascular Calcification in Patients with End-Stage Renal Disease
Nitta, Kosaku
Ogawa, Tetsuya
Hanafusa, Norio
Tsuchiya, Ken
CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 62 - 72
[39] Mineral metabolism and vascular disease in patients with end-stage renal failure - Reply
Klassen, PS
Coladonato, JA
Reddan, DN
Szczech, LA
Owen, WF
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (06): : 696 - 696
[40] Outcomes After Peripheral Vascular Interventions in Patients With End-Stage Renal Disease
Patel, Ankoor H.
Elias, Murad
Goyal, Priya
Hall, Christopher M.
Babu, Sateesh
Laskowski, Igor
JOURNAL OF VASCULAR SURGERY, 2021, 74 (03) : E170 - E170

← 1 2 3 4 5 →